Latest Industry Insights
Optimizing the Discovery of Synthetic Antibodies for SARS-CoV-2
When the COVID-19 global pandemic was declared in March, Twist Biopharma decided to utilize its synthetic antibody discovery libraries to discover antibodies that could have diagnostic or treatment capabilities. Technology Networks spoke with Aaron Sato, Chief Scientific Officer, Twist Biopharma, to find out more.
From Genome Engineering to COVID-19 Diagnostic Testing at IGI
The Innovative Genomics Institute (IGI) has launched an impressive COVID-19 diagnostic testing laboratory at UC Berkeley. Technology Networks spoke with Professor Jennifer Doudna, Executive Director at IGI and Professor of Molecular and Cell Biology and Chemistry at the University of California, Berkeley, to learn exactly how this ambitious effort has been achieved.
13 COVID-19 Vaccines Are in Human Clinical Trials – What Are They?
The World Health Organization recognizes that, as of June 22, there are over 140 vaccines against COVID-19 in various stages of development. 13 of those candidates are now in human clinical trials. In this insights piece, we explore what those candidates are, and who is developing them.
Taking a Closer Look at Trends in Microscopy
With advances in cellular and tissue-based imaging, researchers are able to peel back the layers on new challenges and test hypotheses to solve more problems. We heard about some of the advancements being made in the field of confocal microscopy.
Ramping Up Drug, Vaccine and Infectivity Testing With Airway Organoids
In this article, we take a closer look at the use of lung and airway organoids for drug and vaccine development and explore how they are being used to study infectivity in human respiratory diseases, such as COVID-19.
Improving Gene Editing by Promoting Error-free Repair of CRISPR/Cas9-cut DNA
With the first clinical trial of CRISPR gene editing in progress and the controversy of the first gene-edited babies continuing to spark discussion, it is more important than ever to better understand not only the benefits but also the risks of CRISPR-based therapies.
Three Definitely Isn't a Crowd When It Comes to Protein Complex Analysis
In a study published in Cell Reports, members of the Washburn Lab described their three-pronged approach to analyzing protein complexes – affinity tag protein purification, chemical crosslinking with high-resolution mass spectrometry and computational molecular modeling with protein docking. We interviewed Washburn to find out more.
Finding the Best Cells for Faster Drug Discovery
Advances in developing cell-based therapeutics and products require time-consuming and laborious cell-by-cell manipulation and analysis. Berkeley Lights Inc provide research and development services to help accelerate this process and make it more efficient via their proprietary technology. Technology Networks recently spoke with Mark White, Sr. Director of Marketing, Berkeley Lights Inc to find out more.
A "Plant Paternity Test" To Limit Global Food Wastage
Dr Wirulda Pootakham is a Thai entrepreneur who has created a "plant paternity test" – HybridSure – which enables seed production companies to assess the genetic purity of hybrid seeds faster than traditional methods.
Developing the World's First Single Molecule Protein Sequencer
Jagannath Swaminathan is the co-founder of Erisyon and a researcher at the Marcotte Lab at the University of Texas Austin. In this interview, we discuss the concept of next-generation protein sequencing, clinical proteomics and the critical role of protein sequencing in the fight against COVID-19.